Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trialsY. Wang, Linong Ji, Wenjia Yang et al.|Expert Review of Clinical Pharmacology|2025Cited by 2
PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-AnalysisTingyang Wei, Linong Ji, Fang Lv et al.|Pharmaceuticals|2025Cited by 1